Beijing, China-(BUSINESS WIRE)-October 9, 2009- In the midst of a dramatic increase in drug development partnerships in the Asia-Pacific region, hundreds of global clinical development executives from the pharmaceutical, biotech, and CRO industry will gather on November 8-10 in Beijing to attend the industry's largest annual international conference covering China and North Asia's booming clinical development industry.

The focus of "CHINA TRIALS 2009: Global Clinical Development Summit" is unique, going beyond China outsourcing topics and offering a unique blend of over 85 global speakers, who will share strategies on how to solve the challenges facing the fast-growing list of multinational and local companies already doing drug development in China.  Topics on how to refine and improve China clinical operations and interactions with the SFDA, China's health authority, will be discussed in detail.

The international speaking faculty, made up of over 85 speakers from over 45 pharma and biotech companies includes Allergan, Baxter, Bayer, Biogen Idec, Bristol-Myers Squibb, Celgene, Daiichi-Sankyo, GlaxoSmithKline, Johnson & Johnson, Lundbeck, Merck, Novartis, Novo Nordisk, Pfizer, Roche, Sanofi-Aventis, Schering-Plough, Wyeth and many more.

Nearly all the major players from the CRO and clinical service provider industry will be in attendance including PPD, Quintiles, Covance, Parexel, RPS, i3 Research, Excel Pharmastudies, TigerMed, Fountain Medical Development, Zuellig Pharma, George Clinical, Phase Forward, Marken, Frontage, Fisher Clinical Services, and more.

The conference agenda and registration information can be found by visiting the conference website at www.chinatrialsevent.com.  Some sponsorship/exhibition opportunities are still available.  To explore these opportunities further, or for more information on how to register as Press/Media, please contact the organizer Jon E. Liong at jon.liong@lycheegroup.com or call 86-21-6171-1654.